SR9009 Driada Medical
€72.00
What is SR9009 Driada Medical? – purpose and application
SR9009, commonly marketed by Driada Medical, is a novel synthetic compound known as a Rev-ErbA agonist. This compound mimics exercise-induced benefits by influencing metabolism and fat loss without the need for rigorous physical activity. Originally developed for potential therapeutic use, SR9009 has garnered interest in the sports and fitness community due to its ability to enhance athletic performance. It is primarily utilized for its effects on endurance, fat loss, and the body’s metabolic processes, making it appealing to athletes and fitness enthusiasts seeking an edge in their regimes.
Physiological impact of SR9009 Driada Medical – metabolism and muscle response
The physiological impact of SR9009 is substantial, particularly regarding metabolism and muscle response. By activating Rev-ErbA, SR9009 regulates genes involved in metabolism, thereby promoting increased energy expenditure and reduced fat storage. Studies have suggested that SR9009 can increase the oxidation of fatty acids, leading to enhanced fat utilization as fuel during exercise. This regulation helps in lowering triglyceride levels and improving overall metabolic rates. Furthermore, users often report improved muscle function and recovery times, attributed to the enhanced protein synthesis driven by SR9009. This compound also supports muscle endurance, allowing athletes to train harder and recover faster.
Benefits of using SR9009 Driada Medical – increased endurance and strength
The benefits of using SR9009 Driada Medical are particularly appealing for those looking to maximize their physical capabilities. One of the primary advantages is the noticeable increase in endurance. Users frequently experience prolonged exercise sessions without the usual fatigue, making it easier to push limits. Additionally, SR9009 enhances strength by subsequently boosting muscle performance, providing an opportunity for athletes to achieve higher lifts and improved overall athletic performance. Notably, the compound also aids in fat loss while preserving lean muscle mass, which is crucial for many athletes aiming to maintain a competitive edge. This combination of benefits positions SR9009 as a powerful tool in the arsenal of sports pharmacology.
Contraindications – who should not use it
While SR9009 offers numerous benefits, it is not suitable for everyone. Individuals with pre-existing health conditions such as liver disorders, those taking medications that affect metabolic pathways, or pregnant and nursing women should avoid using SR9009. Additionally, individuals under 18 years of age or those with cardiovascular issues should consult a healthcare provider before considering any use. It’s also essential to ensure that the compound is used responsibly, taking into account the potential for side effects and the importance of adhering to recommended dosages. Safety should always be a priority when incorporating any new supplement into one’s regimen.
How to buy SR9009 Driada Medical safely in our shop – easy ordering and fast delivery
Purchasing SR9009 Driada Medical safely has never been easier. Our shop offers a secure platform for ordering, ensuring that customers receive high-quality products without compromising on safety. To make the process seamless, follow three simple steps:
- Visit our website and choose your desired quantity of SR9009 Driada Medical.
- Add the product to your cart and proceed to checkout, where you can select your preferred payment method.
- Complete your order, and enjoy fast delivery directly to your doorstep.
We prioritize customer satisfaction by providing reliable shipping and exceptional customer support. Embrace your fitness journey with SR9009 Driada Medical and experience the advantages it can offer.
| Active substance | Stenabolic |
|---|---|
| Water Retention | No significant water retention |
| Hepatotoxicity | Not enough data to determine |
| Lab Test | Specific tests for detection in blood or urine not widely detailed |
| Also known as | SR9009, Stenabolic |
| Blood pressure | No significant impact reported |
| Trade name | Not available under any trade name as it is not commercially marketed |
| FORM | 50 tabs x 10 mg/tab |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate |
| Formula | C20H24ClN3O4S |
| Substance class | Synthetic drug, Rev-ErbA ligand |
| Main action | Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage |
| Half-life | Approximately 4-5 hours |
| Dosage (medical) | Not clinically approved for medical use |
| Dosage (sports) | Typically 10-40 mg per day |
| Effects | Increased endurance, reduced fat mass, increased wakefulness |
| Side effects | Potential alterations in circadian rhythms, limited data on long-term effects |
| Use in sports | Used as a performance-enhancing drug, not approved by WADA |
| Manufacturer | Driada Medical |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.